Effects of sodium ferulate on human osteoarthritic chondrocytes and osteoarthritis in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 9, 2009, Pages 912-918

  Shang, Liang ^a,b   Qin, Jun ^a   Chen, Liao Bin ^a   Liu, Bao Xin ^a   Jacques, Magdalou ^c   Wang, Hui ^b  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Biopôle de l Université de Lorraine   (France)

Author keywords

Apoptosis; Matrix metalloproteinase 1; Nitric oxide; Osteoarthritis; Sodium ferulate; Tissue inhibitor of metalloproteinase 1

Indexed keywords

FERULIC ACID; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; NITRIC OXIDE; PAPAIN; PROTEIN BAX;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CARTILAGE CELL; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER DISEASE; NONHUMAN; OSTEOARTHRITIS; RAT; WISTAR RAT;

AGED; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; COUMARIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; KNEE JOINT; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NITRIC OXIDE; OSTEOARTHRITIS, KNEE; PAPAIN; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 69949086740     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05171.x     Document Type: Article

References (47)

1. Brooks PM. Impact of osteoarthritis on individuals and society: How much disability? Social consequences and health economic implications. Curr. Opin. Rheumatol. 2002 14 : 573 577.
2. Lawrence RC, Helmick CG, Arnett FC et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998 41 : 778 799.
3. Buckwalter JA, Heckman JD, Petrie DP. An AOA critical issue. Aging of the North American population: New challenges for orthopaedics. J. Bone Joint Surg. Am. 2003 85 : 748 758.
4. Melchiorri C, Meliconi R, Frizziero L et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 1998 41 : 2165 2174.
5. Westacott CI, Sharif M. Cytokines in osteoarthritis: Mediators or markers of joint destruction? Semin. Arthritis Rheum. 1996 25 : 254 272.
6. Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003 11 : 747 755.
7. Feng L, Precht P, Balakir R, Horton Jr WE. Evidence of a direct role for Bcl-2 in the regulation of articular chondrocyte apoptosis under the conditions of serum withdrawal and retinoic acid treatment. J. Cell. Biochem. 1998 71 : 302 309.
8. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993 74 : 609 619.
9. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: Associations with degenerative changes. Arthritis Rheum. 2001 44 : 585 594.
10. Ishiguro N, Ito T, Ito H et al. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: Analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum. 1999 42 : 129 136.
11. Yoshihara Y, Nakamura H, Obata K et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 2000 59 : 455 461.
12. Graf E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med. 1992 13 : 435 448.
13. Srinivasan M, Sudheer AR, Pillai KR et al. Influence of ferulic acid on gamma-radiation induced DNA damage, lipid peroxidation and antioxidant status in primary culture of isolated rat hepatocytes. Toxicology 2006 228 : 249 258.
14. Yogeeta SK, Gnanapragasam A, Senthilkumar S, Subhashini R, Devaki T. Synergistic salubrious effect of ferulic acid and ascorbic acid on membrane-bound phosphatases and lysosomal hydrolases during experimental myocardial infarction in rats. Life Sci. 2006 80 : 258 263.
15. Perluigi M, Joshi G, Sultana R et al. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J. Neurosci. Res. 2006 84 : 418 426.
16. Balasubashini MS, Rukkumani R, Viswanathan P, Menon VP. Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytother. Res. 2004 18 : 310 314.
17. Wenk GL, McGann GK, Hauss WB et al. Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. J. Neurochem. 2004 89 : 484 493.
18. Khanduja KL, Avti PK, Kumar S et al. Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: A Bcl-2 independent mechanism. Biochim. Biophys. Acta 2006 1760 : 283 289.
19. Lin YS, Huang MH, Chai CY. Effects of helium-neon laser on the mucopolysaccharide induction in experimental osteoarthritic cartilage. Osteoarthritis Cartilage 2006 14 : 377 383.
20. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone Joint Surg. Am. 1971 53 : 523 537.
21. Wu CW, Morrell MR, Heinze E et al. Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores. Semin. Arthritis Rheum. 2005 35 : 197 201.
22. Gouze JN, Bordji K, Gulberti S et al. Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: Influence of glucosamine on interleukin-1beta- mediated effects in rat chondrocytes. Arthritis Rheum. 2001 44 : 351 360.
23. Jungel A, Distler JH, Kurowska SM et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum. 2004 50 : 1468 1476.
24. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction. Cell biology of osteoarthritis. Arthritis Res. 2001 3 : 107 113.
25. Bonassar LJ, Stinn JL, Paguio CG et al. Activation and inhibition of endogenous matrix metalloproteinases in articular cartilage: Effects on composition and biophysical properties. Arch. Biochem. Biophys. 1996 333 : 359 367.
26. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: An overview. Mol. Cell. Biochem. 2003 253 : 269 285.
27. Mazzetti I, Grigolo B, Pulsatelli L et al. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin. Sci. 2001 101 : 593 599.
28. Diaz GL, Prieto JG, Coronel P et al. Apoptosis and nitric oxide in an experimental model of osteoarthritis in rabbit after hyaluronic acid treatment. J. Orthop. Res. 2005 23 : 1370 1376.
29. Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum. 1998 41 : 1266 1274.
30. Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr. Opin. Rheumatol. 1998 10 : 263 268.
31. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 1995 206 : 15 21.
32. Pelletier JP, Jovanovic D, Fernandes JC et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum. 1998 41 : 1275 1286.
33. Bau B, Gebhard PM, Haag J et al. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum. 2002 46 : 2648 2657.
34. Rukkumani R, Aruna K, Varma PS, Menon VP. Influence of ferulic acid on circulatory prooxidant-antioxidant status during alcohol and PUFA induced toxicity. J. Physiol. Pharmacol. 2004 55 : 551 561.
35. Sudheer AR, Muthukumaran S, Kalpana C, Srinivasan M, Menon VP. Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: A comparison with N-acetylcysteine. Toxicol. In Vitro 2007 21 : 576 585. (Pubitemid 46550738)
36. Stagos D, Kouris S, Kouretas D. Plant phenolics protect from bleomycin-induced oxidative stress and mutagenicity in Salmonella typhimurium TA102. Anticancer Res. 2004 24 : 743 745.
37. Kanski J, Aksenova M, Stoyanova A, Butterfield DA. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: Structure-activity studies. J. Nutr. Biochem. 2002 13 : 273 281.
38. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 2001 282 : 1075 1079.
39. Pelletier JP, Jovanovic DV, Lascau CV et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: Possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum. 2000 43 : 1290 1299.
40. 2 via the induction of cyclooxygenase-2. J. Immunol. 2000 165 : 3402 3410.
41. Feng L, Balakir R, Precht P, Horton WE. Bcl-2 regulates chondrocyte morphology and aggrecan gene expression independent of caspase activation and full apoptosis. J. Cell. Biochem. 1999 74 : 576 586.
42. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998 281 : 1312 1316.
43. Vieira O, Escargueil BI, Meilhac O et al. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br. J. Pharmacol. 1998 123 : 565 573.
44. Yu L, Zhang Y, Ma R et al. Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Eur. Neuropsychopharmacol. 2006 16 : 170 177.
45. Jin Y, Yan EZ, Fan Y et al. Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharmacol. Sin. 2005 26 : 943 951.
46. Pay S, Erdem H, Serdar M et al. Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: Is there any difference between rheumatoid arthritis, Behcet's disease and familial Mediterranean fever? Clin. Rheumatol. 2002 21 : 511 515.
47. Naito K, Takahashi M, Kushida K et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: Comparison with generalized osteoarthritis. Rheumatology 1999 38 : 510 515.